Szu‐Tah Chen

1.1k total citations
49 papers, 770 citations indexed

About

Szu‐Tah Chen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Szu‐Tah Chen has authored 49 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Szu‐Tah Chen's work include Thyroid Cancer Diagnosis and Treatment (19 papers), Thyroid and Parathyroid Surgery (11 papers) and Diabetes Treatment and Management (7 papers). Szu‐Tah Chen is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (19 papers), Thyroid and Parathyroid Surgery (11 papers) and Diabetes Treatment and Management (7 papers). Szu‐Tah Chen collaborates with scholars based in Taiwan, United States and United Kingdom. Szu‐Tah Chen's co-authors include Jen‐Der Lin, Chuen Hsueh, Tzu‐Chieh Chao, Bie‐Yu Huang, Hung‐Yu Chang, Jui‐Hung Sun, Yanrong Li, Feng-Hsuan Liu, Shu‐Fu Lin and Miaw‐Jene Liou and has published in prestigious journals such as PLoS ONE, Scientific Reports and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Szu‐Tah Chen

49 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Szu‐Tah Chen Taiwan 17 465 262 158 101 81 49 770
Paola Fierabracci Italy 17 427 0.9× 164 0.6× 141 0.9× 127 1.3× 94 1.2× 44 941
Keiichi Torimoto Japan 14 441 0.9× 167 0.6× 163 1.0× 122 1.2× 61 0.8× 58 777
Xiaoyi Li China 16 489 1.1× 238 0.9× 145 0.9× 76 0.8× 87 1.1× 88 848
Erhard Siegel Germany 16 533 1.1× 252 1.0× 229 1.4× 104 1.0× 122 1.5× 87 998
Müjde Aktürk Türkiye 21 413 0.9× 187 0.7× 219 1.4× 79 0.8× 166 2.0× 80 1.1k
Osmar Monte Brazil 16 436 0.9× 160 0.6× 255 1.6× 225 2.2× 65 0.8× 66 897
Tetsuyuki Yasuda Japan 20 515 1.1× 379 1.4× 319 2.0× 219 2.2× 78 1.0× 47 1.2k
Xiaohan Lu United States 22 530 1.1× 203 0.8× 433 2.7× 50 0.5× 65 0.8× 55 1.3k
Andrew S. Geller United States 9 830 1.8× 350 1.3× 190 1.2× 69 0.7× 71 0.9× 14 1.2k
Vadim V. Klimontov Russia 15 388 0.8× 220 0.8× 170 1.1× 181 1.8× 122 1.5× 101 799

Countries citing papers authored by Szu‐Tah Chen

Since Specialization
Citations

This map shows the geographic impact of Szu‐Tah Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szu‐Tah Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szu‐Tah Chen more than expected).

Fields of papers citing papers by Szu‐Tah Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Szu‐Tah Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szu‐Tah Chen. The network helps show where Szu‐Tah Chen may publish in the future.

Co-authorship network of co-authors of Szu‐Tah Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Szu‐Tah Chen. A scholar is included among the top collaborators of Szu‐Tah Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Szu‐Tah Chen. Szu‐Tah Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Wei‐Chieh, Feng-Hsuan Liu, Hao‐Min Cheng, et al.. (2023). Who needs to be screened for primary aldosteronism?. Journal of the Formosan Medical Association. 123. S82–S90. 4 indexed citations
2.
Lu, Jin‐Ying, Yi‐Yao Chang, Ting‐Wei Lee, et al.. (2023). How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?. Journal of the Formosan Medical Association. 123. S91–S97. 2 indexed citations
3.
Wu, Yi-Hong, Hsiang-Yu Tang, Szu‐Tah Chen, et al.. (2022). Gut Microbiota and Bile Acids Mediate the Clinical Benefits of YH1 in Male Patients with Type 2 Diabetes Mellitus: A Pilot Observational Study. Pharmaceutics. 14(9). 1857–1857. 6 indexed citations
4.
Lin, Wei‐Che, WenChieh Chen, Pei‐Wen Wang, et al.. (2022). 2022 Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation. ULTRASONOGRAPHY. 42(3). 357–375. 16 indexed citations
5.
Lin, Yi‐Hsuan, Chia-Hung Lin, Yu‐Yao Huang, et al.. (2022). Regimen comprising GLP-1 receptor agonist and basal insulin can decrease the effect of food on glycemic variability compared to a pre-mixed insulin regimen. European journal of medical research. 27(1). 273–273. 6 indexed citations
6.
Li, Yanrong, et al.. (2022). Successful Applications of Food-Assisted and -Simulated Training Model of Thyroid Radiofrequency Ablation. Frontiers in Endocrinology. 13. 809835–809835. 2 indexed citations
7.
Lin, Yi‐Hsuan, Chia-Hung Lin, Yu‐Yao Huang, et al.. (2022). Risk factors of first and recurrent genitourinary tract infection in patients with type 2 diabetes treated with SGLT2 inhibitors: A retrospective cohort study. Diabetes Research and Clinical Practice. 186. 109816–109816. 13 indexed citations
8.
9.
Lin, Chia‐Ni, et al.. (2020). Kynurenine/Tryptophan Ratio Predicts Angiotensin Receptor Blocker Responsiveness in Patients with Diabetic Kidney Disease. Diagnostics. 10(4). 207–207. 12 indexed citations
10.
Lin, Yi‐Hsuan, Yu‐Yao Huang, Sheng‐Hwu Hsieh, et al.. (2019). Impact of Carbohydrate on Glucose Variability in Patients with Type 1 Diabetes Assessed Through Professional Continuous Glucose Monitoring: A Retrospective Study. Diabetes Therapy. 10(6). 2289–2304. 11 indexed citations
11.
Lin, Yi‐Hsuan, Yu‐Yao Huang, Sheng‐Hwu Hsieh, et al.. (2019). Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages. Frontiers in Endocrinology. 10. 820–820. 20 indexed citations
12.
Tseng, Fen‐Yu, Tien‐Shang Huang, Jen‐Der Lin, et al.. (2019). A registry of acromegaly patients and one year following up in Taiwan. Journal of the Formosan Medical Association. 118(10). 1430–1437. 8 indexed citations
13.
Lin, Jen‐Der, et al.. (2018). The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis. Nuclear Medicine Communications. 39(12). 1091–1096. 14 indexed citations
14.
Lin, Yi‐Hsuan, et al.. (2018). Computer-Aided Diagnostic Technique in 2-Deoxy-2-[18F]fluoro-D-glucose-Positive Thyroid Nodule: Clinical Experience of 74 Non-thyroid Cancer Patients. Ultrasound in Medicine & Biology. 45(1). 108–121. 5 indexed citations
15.
Lin, Yu‐Sheng, et al.. (2018). Metabolic syndrome positively correlates with the risks of atherosclerosis and diabetes in a Chinese population. European Journal of Internal Medicine. 54. 40–45. 20 indexed citations
16.
Hu, Sindy, Chien‐Wei Chen, Szu‐Tah Chen, et al.. (2018). Inhibitory effect of berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells. International Immunopharmacology. 66. 267–273. 20 indexed citations
17.
Chen, Szu‐Tah, et al.. (2018). A comparison of different definitions of metabolic syndrome for the risks of atherosclerosis and diabetes. Diabetology & Metabolic Syndrome. 10(1). 56–56. 11 indexed citations
18.
Kuo, Sheng‐Fong, et al.. (2017). Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors. International Journal of Endocrinology. 2017. 1–8. 23 indexed citations
19.
Chen, Szu‐Tah, et al.. (2016). Wpływ cukrzycy na przeżycie pacjentów z akromegalią. Endokrynologia Polska. 67(5). 501–506. 11 indexed citations
20.
Chen, Wei-Jan, Wan‐Jing Ho, Gwo‐Jyh Chang, et al.. (2006). Propylthiouracil, independent of its antithyroid effect, produces endothelium-dependent vasodilatation through induction of nitric oxide bioactivity. Atherosclerosis. 196(1). 383–390. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Fierabracci Breakdown of academic impact, for papers by Keiichi Torimoto Breakdown of academic impact, for papers by Xiaoyi Li Breakdown of academic impact, for papers by Erhard Siegel Breakdown of academic impact, for papers by Müjde Aktürk Breakdown of academic impact, for papers by Osmar Monte Breakdown of academic impact, for papers by Tetsuyuki Yasuda Breakdown of academic impact, for papers by Xiaohan Lu Breakdown of academic impact, for papers by Andrew S. Geller Breakdown of academic impact, for papers by Vadim V. Klimontov
Rankless by CCL
2026